Shares of Emerald Health Therapeutics, Inc. (CVE:EMH – Get Free Report) fell 3.8% on Wednesday . The company traded as low as C$0.25 and last traded at C$0.26. 384,329 shares traded hands during mid-day trading, a decline of 40% from the average daily volume of 644,760 shares. The stock had previously closed at C$0.27.
Emerald Health Therapeutics Stock Down 3.8%
The company has a current ratio of 2.97, a quick ratio of 2.61 and a debt-to-equity ratio of 35.45. The firm’s fifty day moving average is C$0.26 and its 200 day moving average is C$0.26. The stock has a market cap of C$52.28 million and a P/E ratio of -0.37.
About Emerald Health Therapeutics
Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015. Emerald Health Therapeutics, Inc is headquartered in Vancouver, Canada.
Featured Stories
- Five stocks we like better than Emerald Health Therapeutics
- SpaceX: Love the Company, But the Stock Is a Harder Call
- Ulta’s Growth Is Real, But So Are the Risks
- BWX Technologies Is Turning the AI Power Problem Into a Nuclear Growth Story
- Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth
Receive News & Ratings for Emerald Health Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emerald Health Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
